{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T07:27:16Z","timestamp":1781854036295,"version":"3.54.5"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.cyto.2023.156298","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:17:10Z","timestamp":1689333430000},"page":"156298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Unleashing the power of formyl peptide receptor 2 in cardiovascular disease"],"prefix":"10.1016","volume":"169","author":[{"given":"Nella","family":"Prevete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo","family":"Poto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9285-4657","authenticated-orcid":false,"given":"Gilda","family":"Varricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1073\/pnas.72.3.1059","article-title":"N-formylmethionyl peptides as chemoattractants for leucocytes","volume":"72","author":"Schiffmann","year":"1975","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","article-title":"Pattern recognition receptors in health and diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10238-021-00750-8","article-title":"Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma","volume":"22","author":"Varricchi","year":"2022","journal-title":"Clin Exp Med"},{"issue":"11","key":"10.1016\/j.cyto.2023.156298_b0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1471-4906(02)02316-5","article-title":"Formyl-peptide receptors revisited","volume":"23","author":"Le","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cyto.2023.156298_b0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phrs.2015.09.017","article-title":"Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth","volume":"102","author":"Prevete","year":"2015","journal-title":"Pharmacol Res"},{"issue":"7","key":"10.1016\/j.cyto.2023.156298_b0035","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.4049\/jimmunol.1202563","article-title":"Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells","volume":"190","author":"Schreiner","year":"2013","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2023.156298_b0040","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4049\/jimmunol.2101039","article-title":"Structural Determinants in the Staphylococcus aureus-Derived Phenol-Soluble Modulin alpha2 Peptide Required for Neutrophil Formyl Peptide Receptor Activation","volume":"208","author":"Viklund","year":"2022","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.cyto.2023.156298_b0045","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1074\/jbc.M114.626747","article-title":"Recognition of bacterial signal peptides by mammalian formyl peptide receptors: a new mechanism for sensing pathogens","volume":"290","author":"Bufe","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbamcr.2014.10.021","article-title":"Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group","volume":"1853","author":"Forsman","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030455","article-title":"The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition","volume":"22","author":"He","year":"2017","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.cyto.2023.156298_b0060","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.4049\/jimmunol.169.8.4559","article-title":"HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors","volume":"169","author":"de Paulis","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0065","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.3390\/ijms14047193","article-title":"Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists","volume":"14","author":"Cattaneo","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"10.1016\/j.cyto.2023.156298_b0070","first-page":"19","article-title":"Hp(2\u201320) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors","volume":"20","author":"Rossi","year":"2012","journal-title":"Infez Med"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0075","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.4049\/jimmunol.174.4.2235","article-title":"A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions","volume":"174","author":"Bellner","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.20041277","article-title":"Identification and characterization of an endogenous chemotactic ligand specific for FPRL2","volume":"201","author":"Migeotte","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2023.156298_b0085","doi-asserted-by":"crossref","first-page":"1119227","DOI":"10.3389\/fendo.2023.1119227","article-title":"Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands","volume":"14","author":"Abouelasrar Salama","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0090","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41467-022-29361-x","article-title":"Structural basis of FPR2 in recognition of Abeta(42) and neuroprotection by humanin","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2023.156298_b0095","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fimmu.2018.00574","article-title":"N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor","volume":"9","author":"Napolitano","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2023.156298_b0100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"De","year":"2000","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pharmthera.2010.04.010","article-title":"Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists","volume":"127","author":"Dufton","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cyto.2023.156298_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.cyto.2023.156298_b0125","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.cyto.2023.156298_b0130","doi-asserted-by":"crossref","first-page":"14354","DOI":"10.1073\/pnas.1918163117","article-title":"Myeloid ALX\/FPR2 regulates vascularization following tissue injury","volume":"117","author":"Sansbury","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/j.cyto.2023.156298_b0135","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1111\/febs.16043","article-title":"Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro","volume":"288","author":"Pessolano","year":"2021","journal-title":"FEBS J"},{"key":"10.1016\/j.cyto.2023.156298_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107879","article-title":"Resolution of inflammation: An organizing principle in biology and medicine","volume":"227","author":"Panigrahy","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cyto.2023.156298_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?","volume":"13","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6593","key":"10.1016\/j.cyto.2023.156298_b0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.abq8310","article-title":"Doubt cast on inflammation's stop signals","volume":"376","author":"Sinha","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cyto.2023.156298_b0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejphar.2018.06.025","article-title":"Targeting formyl peptide receptors to facilitate the resolution of inflammation","volume":"833","author":"Filep","year":"2018","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.cyto.2023.156298_b0160","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.4049\/jimmunol.173.9.5739","article-title":"Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2","volume":"173","author":"de Paulis","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2009.01.068","article-title":"Activation of formyl peptide receptor like-1 by serum amyloid A induces CCL2 production in human umbilical vein endothelial cells","volume":"380","author":"Lee","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.cyto.2023.156298_b0170","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.4049\/jimmunol.0900863","article-title":"Helicobacter pylori Hp(2\u201320) promotes migration and proliferation of gastric epithelial cells by interacting with formyl peptide receptors in vitro and accelerates gastric mucosal healing in vivo","volume":"183","author":"de Paulis","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0175","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1165\/rcmb.2010-0246RC","article-title":"Formyl peptide receptor ligands promote wound closure in lung epithelial cells","volume":"44","author":"Shao","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0180","first-page":"553","article-title":"Role(s) of formyl-peptide receptors expressed in nasal epithelial cells","volume":"25","author":"Prevete","year":"2011","journal-title":"J Biol Regul Homeost Agents"},{"issue":"6","key":"10.1016\/j.cyto.2023.156298_b0185","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1167\/iovs.10-5156","article-title":"Activation of formyl peptide receptor-1 enhances restitution of human retinal pigment epithelial cell monolayer under electric fields","volume":"52","author":"Zhang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"18","key":"10.1016\/j.cyto.2023.156298_b0190","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2174\/1381612824666180516102234","article-title":"Role of Formyl Peptide Receptors in Gastrointestinal Healing","volume":"24","author":"Prevete","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0195","doi-asserted-by":"crossref","first-page":"e1293213","DOI":"10.1080\/2162402X.2017.1293213","article-title":"Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways","volume":"6","author":"Prevete","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.cyto.2023.156298_b0200","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nmicrobiol.2015.21","article-title":"The microenvironment of injured murine gut elicits a local pro-restitutive microbiota","volume":"1","author":"Alam","year":"2016","journal-title":"Nat Microbiol"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0205","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/mi.2013.84","article-title":"Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1","volume":"7","author":"Alam","year":"2014","journal-title":"Mucosal Immunol"},{"issue":"16","key":"10.1016\/j.cyto.2023.156298_b0210","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/1878-0261.13280","article-title":"Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1","volume":"16","author":"Liotti","year":"2022","journal-title":"Mol Oncol"},{"issue":"9","key":"10.1016\/j.cyto.2023.156298_b0215","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/2050640618793564","article-title":"Peptide Hp(2\u201320) accelerates healing of TNBS-induced colitis in the rat","volume":"6","author":"Gravina","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cyto.2023.156298_b0220","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1038\/srep25946","article-title":"Formylpeptide Receptors Promote the Migration and Differentiation of Rat Neural Stem Cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2023.156298_b0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2019.10.008","article-title":"Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure","volume":"31","author":"Tourki","year":"2020","journal-title":"Mol Metab"},{"issue":"21","key":"10.1016\/j.cyto.2023.156298_b0230","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute Myocardial Infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cyto.2023.156298_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061928","article-title":"Vascular Endothelial Growth Factors and Secretory Phospholipase A(2) in Ischemic and Non-Ischemic Heart Failure","volume":"9","author":"Varricchi","year":"2020","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.cyto.2023.156298_b0240","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cyto.2023.156298_b0245","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejim.2022.10.014","article-title":"Angiopoietins, vascular endothelial growth factors and secretory phospholipase A(2) in heart failure patients with preserved ejection fraction","volume":"106","author":"Varricchi","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"7838","key":"10.1016\/j.cyto.2023.156298_b0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0255","doi-asserted-by":"crossref","first-page":"C1304","DOI":"10.1152\/ajpcell.00230.2022","article-title":"Macrophages in myocardial infarction","volume":"323","author":"Kubota","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.cyto.2023.156298_b0260","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.4428","article-title":"IRF3 and type I interferons fuel a fatal response to myocardial infarction","volume":"23","author":"King","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.cyto.2023.156298_b0265","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/cvr\/cvaa287","article-title":"Angiogenesis after acute myocardial infarction","volume":"117","author":"Wu","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cyto.2023.156298_b0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.coi.2018.05.002","article-title":"Innate effector cells in angiogenesis and lymphangiogenesis","volume":"53","author":"Varricchi","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.cyto.2023.156298_b0275","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1189\/jlb.3HI1214-584R","article-title":"Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors","volume":"99","author":"Staiano","year":"2016","journal-title":"J Leukoc Biol"},{"issue":"8","key":"10.1016\/j.cyto.2023.156298_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082012","article-title":"Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment","volume":"10","author":"Braile","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0285","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvu025","article-title":"Cardiac macrophages and their role in ischaemic heart disease","volume":"102","author":"Frantz","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation","volume":"40","author":"Epelman","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","article-title":"Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction","volume":"20","author":"Dick","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cyto.2023.156298_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101602","article-title":"Formyl peptide receptor 2 and heart disease","volume":"59","author":"Lupisella","year":"2022","journal-title":"Semin Immunol"},{"issue":"13","key":"10.1016\/j.cyto.2023.156298_b0305","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1096\/fj.99-0602fje","article-title":"Lipocortin 1 reduces myocardial ischemia-reperfusion injury by affecting local leukocyte recruitment","volume":"14","author":"D'Amico","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.cyto.2023.156298_b0310","first-page":"269","article-title":"Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac(2\u201326)","volume":"10","author":"Qin","year":"2019","journal-title":"Against Myocardial Infarction. Front Pharmacol"},{"issue":"8","key":"10.1016\/j.cyto.2023.156298_b0315","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jacbts.2019.07.005","article-title":"Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment","volume":"4","author":"Garcia","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"8","key":"10.1016\/j.cyto.2023.156298_b0320","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jacbts.2021.07.007","article-title":"Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction","volume":"6","author":"Garcia","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0325","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/stem.2535","article-title":"Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells","volume":"35","author":"Heo","year":"2017","journal-title":"Stem Cells"},{"issue":"23","key":"10.1016\/j.cyto.2023.156298_b0330","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.jacc.2019.03.503","article-title":"Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair","volume":"73","author":"Ferraro","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.cyto.2023.156298_b0335","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020385118","article-title":"Annexin A1 attenuates cardiac diastolic dysfunction in mice with inflammatory arthritis","volume":"118","author":"Chen","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0340","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1038\/s41598-017-10441-8","article-title":"Resolution Agonist 15-epi-Lipoxin A(4) Programs Early Activation of Resolving Phase in Post-Myocardial Infarction Healing","volume":"7","author":"Kain","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0345","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1476-5381.1993.tb12843.x","article-title":"Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1","volume":"108","author":"Cirino","year":"1993","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.cyto.2023.156298_b0350","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1097-2765(00)80323-8","article-title":"A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR","volume":"5","author":"Walther","year":"2000","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/j.cyto.2023.156298_b0355","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/bcp.13149","article-title":"Biomarker-guided clinical development of the first-in-class anti-inflammatory FPR2\/ALX agonist ACT-389949","volume":"83","author":"Stalder","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cyto.2023.156298_b0360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2019.04.030","article-title":"Functional and signaling characterization of the neutrophil FPR2 selective agonist Act-389949","volume":"166","author":"Lind","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"17","key":"10.1016\/j.cyto.2023.156298_b0365","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.1021\/acs.jmedchem.9b02101","article-title":"Discovery of BMS-986235\/LAR-1219: A Potent Formyl Peptide Receptor 2 (FPR2) Selective Agonist for the Prevention of Heart Failure","volume":"63","author":"Asahina","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.cyto.2023.156298_b0370","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1038\/ncomms14232","article-title":"Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice","volume":"8","author":"Qin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2023.156298_b0375","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2015.04.003","article-title":"Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function","volume":"84","author":"Kain","year":"2015","journal-title":"J Mol Cell Cardiol"},{"issue":"14","key":"10.1016\/j.cyto.2023.156298_b0380","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1074\/jbc.271.14.8170","article-title":"Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries","volume":"271","author":"Baek","year":"1996","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.cyto.2023.156298_b0385","doi-asserted-by":"crossref","first-page":"21585","DOI":"10.1074\/jbc.M007769200","article-title":"The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1\/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2","volume":"276","author":"Christophe","year":"2001","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.cyto.2023.156298_b0390","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","article-title":"Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions","volume":"92","author":"Claria","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0090-6980(97)00001-4","article-title":"Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity?","volume":"53","author":"Serhan","year":"1997","journal-title":"Prostaglandins"},{"issue":"14","key":"10.1016\/j.cyto.2023.156298_b0400","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.bmcl.2006.04.068","article-title":"Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents","volume":"16","author":"Burli","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"issue":"6116","key":"10.1016\/j.cyto.2023.156298_b0405","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.cyto.2023.156298_b0410","article-title":"Heart-resident CCR2(+) macrophages promote neutrophil extravasation through TLR9\/MyD88\/CXCL5 signaling. JCI","volume":"1","author":"Li","year":"2016","journal-title":"Insight"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0415","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCRESAHA.115.303567","article-title":"Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction","volume":"115","author":"Heidt","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.cyto.2023.156298_b0420","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacbts.2020.05.005","article-title":"Eosinophil Deficiency Promotes Aberrant Repair and Adverse Remodeling Following Acute Myocardial Infarction","volume":"5","author":"Toor","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"13","key":"10.1016\/j.cyto.2023.156298_b0425","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136778","article-title":"Basophils balance healing after myocardial infarction via IL-4\/IL-13","volume":"131","author":"Sicklinger","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0430","doi-asserted-by":"crossref","first-page":"16615","DOI":"10.1038\/s41598-017-16317-1","article-title":"Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo","volume":"7","author":"Qin","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.cyto.2023.156298_b0435","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med"},{"issue":"17","key":"10.1016\/j.cyto.2023.156298_b0440","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cyto.2023.156298_b0445","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10741-019-09817-x","article-title":"Re-evaluating the causes and consequences of non-resolving inflammation in chronic cardiovascular disease","volume":"25","author":"Pullen","year":"2020","journal-title":"Heart Fail Rev"},{"issue":"5","key":"10.1016\/j.cyto.2023.156298_b0450","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/CIRCRESAHA.116.305825","article-title":"Annexin A1 counteracts chemokine-induced arterial myeloid cell recruitment","volume":"116","author":"Drechsler","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.cyto.2023.156298_b0455","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/srep00786","article-title":"Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes","volume":"2","author":"Liu","year":"2012","journal-title":"Sci Rep"},{"issue":"52","key":"10.1016\/j.cyto.2023.156298_b0460","doi-asserted-by":"crossref","first-page":"36166","DOI":"10.1074\/jbc.M114.612630","article-title":"Identification of a novel recycling sequence in the C-tail of FPR2\/ALX receptor: association with cell protection from apoptosis","volume":"289","author":"Thompson","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.cyto.2023.156298_b0465","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/cvr\/cvu224","article-title":"The role of the FPR2\/ALX receptor in atherosclerosis development and plaque stability","volume":"105","author":"Petri","year":"2015","journal-title":"Cardiovasc Res"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662300176X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104346662300176X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:54:39Z","timestamp":1760910879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104346662300176X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":93,"alternative-id":["S104346662300176X"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156298","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unleashing the power of formyl peptide receptor 2 in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"156298"}}